文献速递呼吸道感染间质性肺疾病肺栓塞与肺血管病

COVID-19呼吸系统后遗症:肺内与肺外起源及临床照护与康复策略

Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitation.
PubMed 文献 · Lancet Respir Med · 2023-05-19

超过三分之一的COVID-19患者症状持续超过3个月,后遗症高度异质并影响多系统,呼吸困难常见。特定肺部后遗症如肺纤维化和血栓栓塞需仔细评估与特殊检查治疗。非药物康复(肺康复、呼吸物理治疗)可能减轻呼吸困难,但仍需研究症状起源与有效康复策略。

要点

  • 超过三分之一COVID-19患者症状持续>3个月,后遗症高度异质。
  • 肺纤维化与血栓栓塞需仔细评估并可能需特殊检查与治疗。
  • 适应肺康复与呼吸物理治疗可能减轻呼吸困难。

核心结论

  • COVID-19后遗症高度异质并影响多系统,呼吸困难常见,部分肺部后遗症需特殊评估治疗。
  • 非药物康复可能减轻呼吸困难,但症状起源与有效康复策略仍需进一步研究。

研究设计与样本

  • 综述,未报告检索范围与样本量。

主要发现

  • 超过三分之一COVID-19患者症状持续超过3个月。
  • 后遗症高度异质并影响多个生物系统,呼吸困难为常被提及的症状。
  • 特定肺部后遗症包括肺纤维化和血栓栓塞性疾病。
  • 肺外并发症如运动耐量下降和衰弱可能促成呼吸困难。
  • 已有呼吸系统疾病者的COVID-19结局因疾病性质、严重程度和控制情况而异。

临床怎么用

  • 对肺纤维化和血栓栓塞等特定肺部后遗症需仔细评估并可能需特殊检查与治疗。
  • 可考虑适应肺康复项目和呼吸管理物理治疗以减轻呼吸困难。
  • 关注肺外并发症如运动耐量下降和衰弱对呼吸困难的影响。

局限性

  • COVID-19后遗症确切患病率未知。
  • 症状起源与病程尚不明确,有效治疗与康复策略仍需研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Although the exact prevalence of post-COVID-19 condition (also known as long COVID) is unknown, more than a third of patients with COVID-19 develop symptoms that persist for more than 3 months after SARS-CoV-2 infection. These sequelae are highly heterogeneous in nature and adversely affect multiple biological systems, although breathlessness is a frequently cited symptom. Specific pulmonary sequelae, including pulmonary fibrosis and thromboembolic disease, need careful assessment and might require particular investigations and treatments. COVID-19 outcomes in people with pre-existing respiratory conditions vary according to the nature and severity of the respiratory disease and how well it is controlled. Extrapulmonary complications such as reduced exercise tolerance and frailty might contribute to breathlessness in post-COVID-19 condition. Non-pharmacological therapeutic options, including adapted pulmonary rehabilitation programmes and physiotherapy techniques for breathing management, might help to attenuate breathlessness in people with post-COVID-19 condition. Further research is needed to understand the origins and course of respiratory symptoms and to develop effective therapeutic and rehabilitative strategies.

来源:Lancet Respir Med,查看原文。版权归原作者所有。

引用

  1. Singh SJ, Baldwin MM, Daynes E, et al. Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitation. Lancet Respir Med. 2023. PMID: 37216955. doi:10.1016/S2213-2600(23)00159-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。